Literature DB >> 15831697

Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance.

Myriam Alcalay1, Enrico Tiacci, Roberta Bergomas, Barbara Bigerna, Elisa Venturini, Simone P Minardi, Natalia Meani, Daniela Diverio, Loris Bernard, Laura Tizzoni, Sara Volorio, Lucilla Luzi, Emanuela Colombo, Francesco Lo Coco, Cristina Mecucci, Brunangelo Falini, Pier Giuseppe Pelicci.   

Abstract

Approximately one third of acute myeloid leukemias (AMLs) are characterized by aberrant cytoplasmic localization of nucleophosmin (NPMc+ AML), consequent to mutations in the NPM putative nucleolar localization signal. These events are mutually exclusive with the major AML-associated chromosomal rearrangements, and are frequently associated with normal karyotype, FLT3 mutations, and multilineage involvement. We report the gene expression profiles of 78 de novo AMLs (72 with normal karyotype; 6 without major chromosomal abnormalities) that were characterized for the subcellular localization and mutation status of NPM. Unsupervised clustering clearly separated NPMc+ from NPMc- AMLs, regardless of the presence of FLT3 mutations or non-major chromosomal rearrangements, supporting the concept that NPMc+ AML represents a distinct entity. The molecular signature of NPMc+ AML includes up-regulation of several genes putatively involved in the maintenance of a stem-cell phenotype, suggesting that NPMc+ AML may derive from a multipotent hematopoietic progenitor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831697     DOI: 10.1182/blood-2005-02-0560

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  98 in total

1.  Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Int J Hematol       Date:  2010-05-08       Impact factor: 2.490

2.  Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.

Authors:  Brunangelo Falini; Maria Paola Martelli; Stefano A Pileri; Cristina Mecucci
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

3.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

Review 4.  The prognostic and functional role of microRNAs in acute myeloid leukemia.

Authors:  Guido Marcucci; Krzysztof Mrózek; Michael D Radmacher; Ramiro Garzon; Clara D Bloomfield
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

5.  Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.

Authors:  June Li; Daniel P Sejas; Sandeep Burma; David J Chen; Qishen Pang
Journal:  Carcinogenesis       Date:  2007-02-02       Impact factor: 4.944

Review 6.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

7.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.

Authors:  Roel G W Verhaak; Bas J Wouters; Claudia A J Erpelinck; Saman Abbas; H Berna Beverloo; Sanne Lugthart; Bob Löwenberg; Ruud Delwel; Peter J M Valk
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

8.  Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.

Authors:  Annika C Russ; Sandrine Sander; Sonja C Lück; Katharina M Lang; Marion Bauer; Frank G Rücker; Hans A Kestler; Richard F Schlenk; Hartmut Döhner; Karlheinz Holzmann; Konstanze Döhner; Lars Bullinger
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

Review 9.  Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

Authors:  Luca Federici; Brunangelo Falini
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

10.  Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

Authors:  David C Taussig; Jacques Vargaftig; Farideh Miraki-Moud; Emmanuel Griessinger; Kirsty Sharrock; Tina Luke; Debra Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.